Correspondence 0001493152-25-010311 from enVVeno Medical Corp (NVNO)

enVVeno Medical Corp
Date: March 14, 2025 · CIK: 0001661053 · Accession: 0001493152-25-010311

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 333-285474

Date

February 28, 2025

Author

Chief

Form

CORRESP

Company

enVVeno Medical Corp

Letter

ENVVENO MEDICAL CORPORATION

Doppler

Irvine, California 92618

March 14, 2025

VIA EDGAR

U.S. Securities and Exchange Commission

Division of Corporation Finance

Office of Life Sciences

F Street, N.E.

Washington, DC 20549

Re: enVVeno Medical Corporation

Registration Statement on Form S-3

Filed February 28, 2025

File No. 333-285474

Ladies and Gentlemen:

Pursuant to Rule 461 under the Securities Act of 1933, as amended, enVVeno Medical Corporation hereby requests acceleration of effectiveness of the above referenced Registration Statement so that it will become effective at 5:30 p.m. EST on Friday, March 14, 2025, or as soon as thereafter practicable.

Very
truly yours,
/s/
Robert Berman

Show Raw Text

CORRESP
 1
 filename1.htm

 ENVVENO
MEDICAL CORPORATION

 70
Doppler

 Irvine,
California 92618

 March
14, 2025

 VIA
EDGAR

 U.S.
Securities and Exchange Commission

 Division
of Corporation Finance

 Office
of Life Sciences

 100
F Street, N.E.

 Washington,
DC 20549

 Re:
 enVVeno
 Medical Corporation

 Registration
 Statement on Form S-3

 Filed
 February 28, 2025

 File
 No. 333-285474

 Ladies
and Gentlemen:

 Pursuant
to Rule 461 under the Securities Act of 1933, as amended, enVVeno Medical Corporation hereby requests acceleration of effectiveness of
the above referenced Registration Statement so that it will become effective at 5:30 p.m. EST on Friday, March 14, 2025, or as soon as
thereafter practicable.

 Very
 truly yours,

 /s/
 Robert Berman

 Robert
 Berman

 Chief
 Executive Officer

 cc:
 Ellenoff
 Grossman & Schole LLP

SecProbe.io